Back to Bahl & Gaynor LLC Bahl & Gaynor LLC

RMDRMD

Showing 9 of 31 quarters

Position history for Bahl & Gaynor LLCBahl & Gaynor LLC's holdings in ResMed Inc.

Yes. Bahl & Gaynor holds 33,045 shares of RMD (ResMed), worth $7.3M, as of its Q3 2026 13F filing. It reduced the position by 1,480 shares (-4.3%) from Q2 2026. Bahl & Gaynor has held RMD in every 13F on record since Q1 2019, 31 quarterly filings.

Current Value

$7.3M

Current Shares

33,045

Total Value Change

-$2.5M

Total Shares Change

-7,128

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
33,045
-4.3%
$7.3M0.0%$221.10
0
2026-Q2
Decreased
34,525
-0.4%
$6.7M0.0%$194.32
0
2026-Q1
Decreased
34,655
-2.1%
$7.8M0.0%$223.17
0
2025-Q4
Decreased
35,390
-0.5%
$8.5M0.0%$238.92
0
2025-Q3
Unchanged
35,565
0.0%
$9.7M0.0%$270.86
0
2025-Q2
Decreased
35,565
-6.2%
$9.2M0.0%$254.77
0
2025-Q1
Decreased
37,899
-1.8%
$8.5M0.0%$220.57
0
2024-Q4
Decreased
38,579
-4.0%
$8.8M0.0%$224.83
0
2024-Q3
Decreased
40,173
-4.0%
$9.8M0.1%$239.48
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used